Replies to post #581 on Trius Therapeutics, Inc. (TSRX)

[TRUISM]

Trius is definitely on the radar now.

I wouldn't be surprised if there are already discussions with other pharmaceutical companies.

The company is undervalued (considering the other projects underway) but once you add the NDA filing,the value increases. A favorable European decision on Tedezolid towards year's end will take this company to another level entirely.

This just covers the remainder of 2013.

Optimistic times indeed for TSRX.


Take Care and God Bless....God Bless Us All.


Truth4Once